...
OGNSMALL

Organon & Co.

HealthcareDrug Manufacturers - General
$7.29
$0.00(+0.83%)
52W$6.18
$16.08
Updated Mar 2, 12:00 AM
RSI39
RS Rating30/99
Beta0.92
Volatility63%
F-Score0/9
Mkt Cap$1.9B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Organon & Co. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 30), showing significant lag compared to the market leaders. Earnings contraction of 288% provides fundamental context to the price action. Investors should exercise caution due to high volatility (63% annualized), which requires wider risk management.

Relative Strength
30
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.92
vs S&P 500
MARKET
52W Position
11%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$8.00
50 SMA > 100 SMA$7.92
100 SMA > 150 SMA$8.57
150 SMA > 200 SMA$8.83

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$7.79-6.40%BELOW
50 SMA$8.00-8.83%BELOW
100 SMA$7.92-7.92%BELOW
150 SMA$8.57-14.97%BELOW
200 SMA$8.83-17.44%BELOW

Price Performance

1D+0.8%
1W-8.0%
1M-18.0%
3M-5.4%
6M-20.6%
YTD+0.7%
1Y-51.1%
3Y-33.2%
52-Week Trading Range11% from low
$7.29
52W Low$6.18
52W High$16.08

Technical Indicators

RSI (14)BEARISH
39.2
305070
VCP ScoreCOOL
3/10
Base depth: 47.2%

Risk Profile

Beta
0.92
52W Vol
63%
ATR
$0.41
Max DD (1Y)
-60%

Volume Analysis

Today
7
50D Avg
4.77M
Vol Ratio
0.00x
Liquidity
MODERATE

Earnings Momentum

Q1'25-58%
$0.33
Q2'25-25%
$0.56
Q3'25-56%
$0.61
Q4'25-288%
$-0.79
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:-0.99%
3 Years:+0.23%
TTM:-2.92%

Compounded Profit Growth

10 Years:
5 Years:-38.99%
3 Years:-41.47%
TTM:-78.68%

Stock Price CAGR

10 Years:-14.08%
5 Years:-26.18%
3 Years:-33.23%
1 Year:-51.11%

Return on Equity

10Y Avg:106.9%
5Y Avg:175.0%
3Y Avg:228.5%
Last Year:20.6%

Key Metrics

Market Cap$1.9B
Gross Margin54.1%
Net Margin3.0%
Piotroski F-Score0/9

Frequently Asked Questions

Is OGN in an uptrend right now?

OGN has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is OGN overbought or oversold?

OGN's RSI (14) is 39. The stock is in neutral territory, neither overbought nor oversold.

Is OGN outperforming the market?

OGN has a Relative Strength (RS) Rating of 30 out of 99. OGN is currently lagging the broader market.

Where is OGN in its 52-week range?

OGN is trading at $7.29, which is 45% of its 52-week high ($16.08) and 11% above its 52-week low ($6.18).

How volatile is OGN?

OGN has a Beta of 0.92 and 52-week volatility of 63%. It's less volatile than the S&P 500 - generally more stable.